NASDAQ · NKGN
Healthcare · Biotechnology
$0.01
Up-$0.00 (+0.00%)
Updated Aug 14, 2026, 3:20 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
NKGN does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning NKGN.
NKGN research
Company profile and research snapshot.
NKGEN BIOTECH INC
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
defenseworld.net · Dec 11, 2025
Profitability This table compares Genocea Biosciences and NKGen Biotech's net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Genocea Biosciences N/A -182.88% -62.76% NKGen Biotech N/A N/A -479.36% Insider and Institutional Ownership 0.6% of Genocea Biosciences shares are owned by institutional investors. Comparatively, 76.2% of NKGen Biotech
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning NKGN.
